Indeed, changes of HNRNPA1 and HNRNPA2 expression can improve the condition of patients with amyotrophic lateral sclerosis, spinal muscular atrophy, Alzheimer’s disease, and other neurodegenerative diseases (Bekenstein and Soreq, 2013). This evidence concerns the gene HNRNPA2B1 and neurodegenerative disease.